散人逍遥游
09-22
$瑞博生物-B(06938)$
小核酸赛道全球都稀缺,瑞博的肝外递送技术是独门绝活,中报首次实现净利润为正,意味着商业化潜力开始释放了
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":610439019667968,"tweetId":"610439019667968","gmtCreate":1790059654914,"gmtModify":1790059657342,"author":{"id":4129245819787500,"idStr":"4129245819787500","authorId":4129245819787500,"authorIdStr":"4129245819787500","name":"散人逍遥游","avatar":"https://static.tigerbbs.com/1e8d507ee499664325f52bd0df9a4f68","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/06938\">$瑞博生物-B(06938)$</a>小核酸赛道全球都稀缺,瑞博的肝外递送技术是独门绝活,中报首次实现净利润为正,意味着商业化潜力开始释放了</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/06938\">$瑞博生物-B(06938)$</a>小核酸赛道全球都稀缺,瑞博的肝外递送技术是独门绝活,中报首次实现净利润为正,意味着商业化潜力开始释放了</body></html>","text":"$瑞博生物-B(06938)$小核酸赛道全球都稀缺,瑞博的肝外递送技术是独门绝活,中报首次实现净利润为正,意味着商业化潜力开始释放了","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/610439019667968","repostId":0,"isVote":1,"tweetType":1,"viewCount":699,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06938"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":118,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/610439019667968"}
精彩评论